HighVista Strategies’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,574
| Closed | -$522K | – | 144 |
|
|
2024
Q3 | $522K | Buy |
+15,574
| New | +$522K | 0.18% | 128 |
|
|
2023
Q3 | – | Sell |
-37,651
| Closed | -$766K | – | 135 |
|
|
2023
Q2 | $766K | Buy |
37,651
+12,432
| +49% | +$253K | 0.35% | 73 |
|
|
2023
Q1 | $549K | Buy |
25,219
+11,215
| +80% | +$244K | 0.45% | 69 |
|
|
2022
Q4 | $434K | Sell |
14,004
-22,983
| -62% | -$712K | 0.26% | 79 |
|
|
2022
Q3 | $944K | Buy |
36,987
+3,884
| +12% | +$99.1K | 0.54% | 44 |
|
|
2022
Q2 | $672K | Buy |
33,103
+19,105
| +136% | +$388K | 0.41% | 58 |
|
|
2022
Q1 | $346K | Buy |
+13,998
| New | +$346K | 0.22% | 85 |
|